Articles tagged "Weight"

2020 American Transplant Congress
Outcomes Associated with Mycophenolate Weight-Based Dosing in Varying Immunologic Risk Kidney Transplant Recipients
A. A. Al-Bahou, A. R. Webb, M. Bloxam, L. J. Bowman Anger, R. S. Baliga, A. J. Brueckner
Tampa General Hospital, Tampa, FL
*Purpose: Mycophenolate acid (MPA) is traditionally dosed in kidney transplant recipients (KTR) using the FDA-approved fixed dosing which is irrespective of patient-specific variables such as…
2020 American Transplant Congress
The Influence of the Donor Kidney Weight to Recipient Body Weight Ratio on Long-Term Renal Graft Outcomes
S. Yang¹, J. Lee¹, Y. Jung², B. Kim³, M. Kim¹, S. Kim¹, Y. Kim¹, K. Huh¹
¹Department of Transplantation Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of, ²Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of, ³Department of Nephrology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
*Purpose: To study the impact of the relative donor kidney size on long-term graft function and survival, we investigated the living donor renal transplants outcomes.*Methods:…
2020 American Transplant Congress
Safety Outcomes in Lower-Weight vs Higher-Weight Recipients of Fixed Dose Alemtuzumab for Kidney Transplant Induction
A. Freeman, S. Anders, B. Wise, M. Janusek, L. Hutchinson, U. Kaszubski, D. Marroquin, D. Martin, H. Bohorquez
Ochsner Medical Center, New Orleans, LA
*Purpose: Alemtuzumab is a lymphocyte-depleting monoclonal antibody used for renal transplant induction, and is associated with significant leukopenia, increased infections and malignancy. Multiple dosing strategies…
2020 American Transplant Congress
Non-Linear Relationship between Recipient BMI and Survival Outcomes after Liver Transplantation-A Dose-Response Meta-Analysis
T. Song
Organ Transplantation Center, Urology Department, Urology Research Institute, West China Hospital, Sichuan University, Chengdu City, China
*Purpose: Dose-response relationship between preoperative and postoperative body mass index (BMI) and survival outcomes after liver transplantation (LT) has not been clearly defined yet.*Methods: PubMed,…
2020 American Transplant Congress
Pre-Transplant Bariatric Surgery is Not Associated with Increased Risk of Infection after Kidney Transplant
E. Joachim, M. Jorgenson, B. C. Astor, J. Smith, K. Swanson, M. Mohamed, F. Aziz, N. Garg, A. Djamali, D. Mandelbrot, S. Parajuli
University of Wisconsin, Madison, WI
*Purpose: Bariatric surgery (BS) is a highly effective weight loss strategy that is increasingly common, but can be associated with impaired drug absorption and alterations…
2019 American Transplant Congress
Expression of Prostaglandin E2 Receptors Track with Rejection in Porcine Kidney Transplants
A. Harner¹, Y. Wang², X. Fang², R. Lassiter¹, T. D. Merchen¹, S. Ho³, S. Nahman Jr²
¹Surgery, Augusta University, Augusta, GA, ²Nephrology, Augusta University, Augusta, GA, ³Gift of Life Michigan, Ann Arbor, MI
*Purpose: Prostaglandin E2 (PGE2) is generated from arachidonic acid via cyclooxygenase-2 (COX2) and is known to modulate the immune response via its receptors: EP1, EP2,…
2019 American Transplant Congress
Feasibility of a Rapid Magnetic Resonance Protocol to Assess Body Composition Profiles in Adult Liver Transplant Candidates
S. Pine¹, L. Adamski¹, D. Gregory¹, C. Padilla¹, J. Gottstein², A. Lemmer¹, M. Forsgren³, M. Rinella¹, L. B. VanWagner⁴
¹Medicine-GI & Hepatology, Northwestern University, Chicago, IL, ²Northwestern University, Chicago, IL, ³Center for Medical Image Science, Linköping University, Linköping, Sweden, ⁴Medicine-GI & Hepatology and Preventive Medicine, Northwestern University, Chicago, IL
*Purpose: Body mass index (BMI) is a poor marker of obesity and outcomes in liver transplant (LT) candidates. Data suggest that body composition profiling (BCP),…
2019 American Transplant Congress
Etiology of Liver Disease Affects Weight Gain after Liver Transplant
A. Chandrakumaran¹, M. B. Siddiqui², S. Patel², F. Lin³, J. Laurenzano², J. Clinton², T. Reichman⁴, C. Bhati⁴, M. S. Siddiqui²
¹Internal Medicine, Virginia Commonwealth University, Richmond, VA, ²Gastroenterology & Hepatology, Virginia Commonwealth University, Richmond, VA, ³Virginia Commonwealth University, Richmond, VA, ⁴Transplant Surgery, Virginia Commonwealth University, Richmond, VA
*Purpose: Weight gain after liver transplant (LT) is a key driver of cardiometabolic disease and associated mortality. There is little known about trends in post-LT…
2019 American Transplant Congress
Changes in Body Mass Index and Outcomes after Kidney Transplantation: A Single Centre, Retrospective, Observational Study
A. Arshad¹, J. Hodson², K. Khalil¹, A. Sharif³
¹University of Birmingham, Birmingham, United Kingdom, ²Queen Elizabeth Hospital, Edgbaston, Birmingham, UK, Institute of Translational Medicine, Birmingham, United Kingdom, ³Queen Elizabeth Hospital Birmingham, UK, Department of Nephrology and Transplantation, Birmingham, United Kingdom
*Purpose: The aim of this study was to describe the changes in body mass index (BMI) after kidney transplantation and assess how this influences long-term…
2019 American Transplant Congress
Use of GLP-1 Receptor Agonists in Kidney Transplant Recipients with Type 2 Diabetes
A. Kukla, J. Hill, M. Merzkani, A. Bentall, E. Lorenz, W. Park, P. Shah, N. Issa, M. Stegall
Mayo Clinic, Rochester, MN
*Purpose: GLP-1 receptor agonists have been shown to improve glucose control and diabetes-related comorbidities, including obesity, cardiovascular disease and chronic kidney disease, in non-transplant patients.…